Roberta Romero
Nurse Practitioner · San Antonio, TXNPI 1871826818
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (54.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Gilead at 53.5% of the total. Reporting peaked in 2022 at $16,733 and has fallen 82.1% since, to $2,988 in 2025. Among nurse practitioner clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 308 payments — averaging $84.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$14K
- AbbVie$7K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$996
- Johnson & Johnson$729
- Intercept Pharmaceuticals, Inc.$637
- Takeda Pharmaceuticals U.S.A., Inc.$624
- plus $2K from 14 others
What the payments were for
- Consulting fees$7003%
- Speaking & faculty fees$14,26055%
- Travel & lodging$3,03412%
- Food & beverage$8,03931%
- Education$840%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 49 | $13,964 |
| AbbVie | 74 | $7,082 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 59 | $996 |
| Johnson & Johnson(2 entities) | 29 | $729 |
| Intercept Pharmaceuticals, Inc. | 6 | $637 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $624 |
| Ardelyx, Inc. | 20 | $570 |
| Pfizer | 11 | $318 |
| Madrigal Pharmaceuticals | 5 | $307 |
| Daiichi Sankyo Inc. | 12 | $194 |
| Enterra Medical, Inc. | 1 | $160 |
| Novo Nordisk | 2 | $138 |
| E.r. Squibb & Sons, L.L.C. | 2 | $112 |
| Nestle Healthcare Nutrition Inc. | 6 | $103 |
| Merck | 4 | $59 |
| Alnylam Pharmaceuticals Inc. | 3 | $54 |
| Endogastric Solutions, Inc | 2 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
| Redhill Biopharma Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$26,116 in reported general payments places this provider in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Other nurse practitioner in San Antonio
- Corrie BerkSan Antonio$155K
- Sonja BruneSan Antonio$51K
- Laura GalvanSan Antonio$32K
- Eduardo GonzalezSan Antonio$32K
- Christopher GarciaSan Antonio$21K
- Jennifer ZavalaSan Antonio$17K
- Amy RivasSan Antonio$17K
- Alexis WahlenSan Antonio$16K
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.